[Pregnanetriolone excretion after stimulation with ACTH as a test on presumably heterozygous carriers of a 21-hydroxylase-deficiency (author's transl)].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000312:Adrenal Hyperplasia, Congenital / Q000201:enzymology / Q000235:genetics / Q000652:urine*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000738:Androsterone / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000235:genetics / Q000652:urine*; D006899:Mixed Function Oxygenases / Q000378:metabolism* / Q000652:urine; D011276:Pregnanediol / Q000652:urine; D011279:Pregnanetriol / Q000652:urine*; D013268:Stimulation, Chemical
D015065:17-Hydroxycorticosteroids; D011279:Pregnanetriol; D000324:Adrenocorticotropic Hormone; D000738:Androsterone; D006899:Mixed Function Oxygenases; D011276:Pregnanediol
Pregnantriolonausscheidung nach ACTH-Stimulierung als Test auf vermutliche heterozygote Erbmerkmalsträger eines 21-Hydroxylasemangels